(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

M

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

M

ST13

US500000098496929

Class

5

Filing

98496929

Registration

8111953

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

18

Latest update

01/20/2026

Trademark type

Combined

Nice classes

5

Filing date

04/12/2024

Registration date

01/20/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/20/2026

Last transaction

01/20/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/30/2024

First use in commerce

06/30/2024

Drawing code

3

Owner type

16

Owner location

Parsippany, NJ, US

Examiner

FOSTER, SHATONI A

Law office

N30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the letter "M" raised on a three-dimensional design of a circular gummy tablet. The broken lines depicting the shape of the gummy tablet indicate placement of the mark on the goods and the circular shape depicted in broken lines, alone or separate from the other elements, is not claimed.

Holders and representatives

Holders

RB Health (US) LLC

Representatives

Mark Lerner, Esq. DUANE MORRIS LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; decongestants; cough suppressant; pharmaceutical antitussive-cold preparations; preparations for treating colds.

Publications

History of USPTO decisions and trademark events.

18 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/20/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

01/20/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/30/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/30/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/23/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/23/2025

IUAF

USE AMENDMENT FILED

06/23/2025

EISU

TEAS STATEMENT OF USE RECEIVED

06/23/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/31/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/19/2024

PUBO

PUBLISHED FOR OPPOSITION

11/19/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/13/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/07/2024

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

10/07/2024

DOCK

ASSIGNED TO EXAMINER

10/04/2024

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/26/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/26/2024

NWAP

NEW APPLICATION ENTERED

04/12/2024

Continuous trademark protection

Get notified about every new filing that threatens M or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.